{reportSlug=global-chemotherapy-induced-peripheral-neuropathy-treatment-market, reportId=56412, mktKeyword=Chemotherapy Induced Peripheral Neuropathy Treatment, cagr=0.00, publishDate=Aug 2024, priceOption2=7000, reportTitle=Chemotherapy Induced Peripheral Neuropathy Treatment Comprehensive Study by Type (APX-3330, BR-297, Cannabidiol, Dimiracetam, Others), Application (Platinum Agents, Taxanes, Vinca Alkaloids, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=200, priceOption1=3500, forecastYr=2030, noOfPages=244, reportKey=56106, breadcrum=Chemotherapy Induced Peripheral Neuropathy Treatment}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Aug 2024 244 Pages 62 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner